Erratum: Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: A retrospective single-center study (Lupus (2015) 24 (1067-1075) DOI: 10.1177/0961203315578766);Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: A retrospective single-center study

Lupus

Volumn 24, Issue 10, 2015, Pages 1067-1075

  Hu, W X ^a   Chen, Y H ^a   Bao, H ^a   Liu, Z Z ^a   Wang, S F ^a   Zhang, H T ^a   Liu, Z H ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

glucocorticoid; immunosuppressant; Lupus podocytopathy; relapse; remission

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; LIVER ENZYME; MYCOPHENOLATE MOFETIL; PREDNISONE; TACROLIMUS; TRIPTERYGIUM WILFORDII EXTRACT; ISOXAZOLE DERIVATIVE; MYCOPHENOLIC ACID;

ACUTE APPENDICITIS; ADULT; ARTICLE; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DIABETES MELLITUS; DRUG DOSE REDUCTION; FEMALE; FEMUR HEAD NECROSIS; GLAUCOMA; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; LEUKOPENIA; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS PODOCYTOPATHY; MAINTENANCE THERAPY; MALE; MENSTRUATION DISORDER; MONOTHERAPY; MOUTH INFECTION; PNEUMONIA; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SIDE EFFECT; SKIN INFECTION; STEROID THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE; URINARY TRACT INFECTION; ADOLESCENT; ANALOGS AND DERIVATIVES; COMBINATION DRUG THERAPY; FOLLOW UP; KIDNEY; LUPUS NEPHRITIS; NEPHROTIC SYNDROME; PATHOLOGY; PODOCYTE; PROTEINURIA; URINE;

ADOLESCENT; ADULT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KIDNEY; LUPUS NEPHRITIS; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PODOCYTES; PREDNISONE; PROTEINURIA; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 84938786230     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203315605243     Document Type: Erratum

References (40)

1. Kraft SW, Schwartz MM, Korbet SM,. Glomerular podocytopathy in patients with systemic lupus erythematosus. J Am Soc Nephrol 2005; 16: 175-179.
2. Han TS, Schwartz MM, Lewis EJ,. Association of glomerular podocytopathy and nephrotic proteinuria in mesangial lupus nephritis. Lupus 2006; 15: 71-75.
3. Shea-Simonds P, Cairns TD, Roufosse C,. Lupus podocytopathy. Rheumatology (Oxford) 2009; 48: 1616-1618.
4. Mok CC, Cheung TT, Lo WH,. Minimal mesangial lupus nephritis: A systematic review. Scand J Rheumatol 2010; 39: 181-189.
5. Gutiérrez S, Petiti JP, De Paul AL,. Lupus-related podocytopathy. Could it be a new entity within the spectrum of lupus nephritis? Nefrologia 2012; 32: 245-246.
6. Matsumura N, Dohi K, Shiiki H,. Three cases presenting with systemic lupus erythematosus and minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi 1989; 31: 991-999.
7. Okai T, Soejima A, Suzuki M,. A case report of lupus nephritis associated with minimal change nephrotic syndrome-comparison of various histological types of 67 cases with lupus nephritis. Nihon Jinzo Gakkai Shi 1992; 34: 835-840.
8. Makino H, Haramoto T, Shikata K,. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus. Am J Nephrol 1995; 15: 439-441.
9. Moyses-Neto M, Costa RS, Rodrigues FF,. Minimal change disease: A variant of lupus nephritis. NDT Plus 2011; 4: 20-22.
10. Horita Y, Nazneen A, Cheng M,. A case of systemic lupus erythematosus associated with minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi 1997; 39: 759-764.
11. Nishihara G, Nakamoto M, Yasunaga C,. Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome. Clin Nephrol 1997; 48: 327-330.
12. Dube GK, Markowitz GS, Radhakrishnan J,. Minimal change disease in systemic lupus erythematosus. Clin Nephrol 2002; 57: 120-126.
13. Wang YT, Chou HH, Chen FF,. A case of minimal-change nephrotic syndrome in pediatric lupus erythematosus: Just a coincidence? Lupus 2006; 15: 244-247.
14. Hertig A, Droz D, Lesavre P,. SLE and idiopathic nephrotic syndrome: Coincidence or not? Am J Kidney Dis 2002; 40: 1179-1184.
15. Stankeviciute N, Jao W, Bakir A,. Mesangial lupus nephritis with associated nephrotic syndrome. J Am Soc Nephrol 1997; 8: 1199-1204.
16. Watanabe T,. Nephrotic syndrome in mesangial proliferative lupus nephritis. Pediatr Int 2007; 49: 1009-1011.
17. Deji N, Sugimoto T, Kanasaki M,. Emerging minimal-change nephrotic syndrome in a patient with chronic mesangial proliferative lupus nephritis. Intern Med 2007; 46: 991-995.
18. Hickman PL, Nolph KD, Jacobs R,. Idiopathic focal segmental glomerulosclerosis in a patients with systemic lupus erythematosus: An unusual combination. Am J Kidney Dis 1994; 23: 582-586.
19. Haas M,. Collapsing glomerulopathy in systemic lupus erythematosus: An extreme form of lupus podocytopathy? Clin J Am Nephrol 2012; 7: 878-880.
20. Salvatore SP, Barisoni LM, Herzenberg AM,. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease. Clin J Am Soc Nephrol 2012; 7: 914-925.
21. Seo DB, Lee SW, Song JH,. Acute renal failure associated with a minimal change nephrotic syndrome in a systemic lupus erythematosus patient. Yonsei Med J 2002; 43: 114-118.
22. Sugimoto T, Yamasaki Y, Kobayashi M,. A case of minimal change nephrotic syndrome manifesting acute renal failure in the course of systemic lupus erythematosus. Nihon Jinzo Gakkai Shi 2002; 44: 476-482.
23. Iwazu Y, Akimoto T, Izawa S,. Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy. Clin Exp Nephrol 2012; 16: 485-489.
24. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO Clinical Practice Guideline for Glomerulonephritis. Chapter 12: Lupus nephritis. Kidney Int Suppl 2012; 2: 221-232.
25. Hahn BH, McMahon MA, Wilkinson A,. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 2012; 64: 797-808.
26. Bertsias GK, Tektonidou M, Amoura Z,. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771-1782.
27. Huong DL, Papo T, Beaufils H,. Renal involvement in systemic lupus erythematosus. A study of 180 patients from a single center. Medicine (Baltimore) 1999; 78: 148-166.
28. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1734.
29. Weening JJ, D'Agati VD, Schwartz MM,. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004; 65: 521-530.
30. Mehta RL, Kellum JA, Shah SV,. Acute Kidney Injury Network network (AKIN): Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31-R31.
31. Ito I, Nishida M, Morioka S,. A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus. Lupus 2014; 23: 703-706.
32. Hong YH, Yun DY, Jung YW,. A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus. Korean J Intern Med 2011; 26: 470-473.
33. Shahane A, Khasnis A, Gota C,. Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus. J Clin Rheumatol 2012; 18: 199-202.
34. Dooley MA, Jayne D, Ginzler EM,. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis. N Engl J Med 2011; 365: 1886-1895.
35. Perysinaki GS1, Moysiadis DK, Bertsias G,. Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology. Lupus 2011; 20: 781-791.
36. Desai N, Cimbaluk D, Lewis EJ,. Proteinuria in membranous lupus nephritis: The pathology is in the podocyte. Lupus 2013; 22: 461-468.
37. Wang Y, Yu F, Song D,. Podocyte involvement in lupus nephritis based on the 2003 ISN/RPS system: A large cohort study from a single centre. Rheumatology (Oxford) 2014; 53: 1235-1244.
38. Qin DD, Song D, Huang J,. Plasma-soluble urokinase-type plasminogen activator receptor levels are associated with clinical and pathological activities in lupus nephritis: A large cohort study from China. Lupus. Epub ahead of print 18 November 2014. DOI: 0961203314558857.
39. Moysiadis DK, Perysinaki GS, Bertsias G,. Early treatment with glucocorticoids or cyclophosphamide retains the slit diaphragm proteins nephrin and podocin in experimental lupus nephritis. Lupus 2012; 21: 1196-1207.
40. Faul C, Donnelly M, Merscher-Gomez S,. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008; 14: 931-938.